Nova Leap Health Corp. Grants Deferred Share Units
01 Abril 2022 - 2:16PM
NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”),
a growing home health care organization, is pleased to announce
that the Company issued Deferred Share Units (“DSUs”).
A total of 80,792 DSUs were issued to
independent directors of the Company as settlement for the
directors’ compensation for the three months ended March 31, 2022.
On an annual basis, directors may elect to have all, or a portion
of, their annual compensation to be paid in DSUs. The DSUs were
granted under, and are subject to the terms and conditions of, the
Company’s Amended and Restated Equity Incentive
Plan.
About Nova Leap
Nova Leap is an acquisitive home health care
services company operating in one of the fastest-growing industries
in the U.S. & Canada. The Company performs a vital role within
the continuum of care with an individual and family centered focus,
particularly those requiring dementia care. Nova Leap achieved the
#42 ranking on the 2021 Report on Business ranking of Canada’s Top
Growing Companies, the #2 ranking on the 2020 Report on Business
ranking of Canada’s Top Growing Companies and the #10 Ranking in
the 2019 TSX Venture 50™ in the Clean Technology & Life
Sciences sector. The Company is geographically diversified with
operations in 11 different U.S. states within the New England,
Southeastern, South Central and Midwest regions as well as Nova
Scotia, Canada.
FORWARD LOOKING
INFORMATION:
Certain information in this press release may
contain forward-looking statements, such as statements regarding
future expansions and cost savings, timing of receipt of ERC, and
plans regarding future acquisitions and business growth, including
the timing of closing recently announced acquisitions, anticipated
annualized revenue or annualized recurring revenue run rate growth
and anticipated consolidated Adjusted EBITDA margins. This
information is based on current expectations and assumptions,
including assumptions described elsewhere in this release and those
concerning general economic and market conditions, availability of
working capital necessary for conducting Nova Leap’s operations,
availability of desirable acquisition targets and financing to fund
such acquisitions, and Nova Leap’s ability to integrate its
acquired businesses and maintain previously achieved service hour
and revenue levels, that are subject to significant risks and
uncertainties that are difficult to predict. Actual results might
differ materially from results suggested in any forward-looking
statements. Risks that could cause results to differ from those
stated in the forward-looking statements in this release include
the impact of the COVID-19 pandemic or any recurrence, including
government regulations or voluntary measures limiting the Company’s
ability to provide care to clients (such as shelter-in-place
orders, isolation or quarantine orders, distancing requirements, or
closures or restricted access procedures at facilities where
clients reside), increased costs associated with personal
protective equipment and sanitization supplies, staff and supply
shortages, regulatory changes affecting the home care industry or
government programs utilized by the Company (such as ERC), other
unexpected increases in operating costs and competition from other
service providers. All forward-looking statements, including any
financial outlook or future-oriented financial information,
contained in this press release are made as of the date of this
release and included for the purpose of providing information about
management's current expectations and plans relating to the future,
and these statements may not be appropriate for other purposes. The
Company assumes no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those reflected in the forward-looking statements
unless and until required by securities laws applicable to the
Company. Additional information identifying risks and uncertainties
is contained in the Company's filings with the Canadian securities
regulators, which filings are available at www.sedar.com.
CAUTIONARY STATEMENT:
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information:
Chris Dobbin, CPA, CA, ICD.D
Director, President and CEO
T: 902 401 9480
E:cdobbin@novaleaphealth.com
Nova Leap Health (TSXV:NLH)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Nova Leap Health (TSXV:NLH)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024